人民卫生出版社系列期刊
ISSN 2096-2738 CN 11-9370/R

中国科技核心期刊(中国科技论文统计源期刊)
中国科学引文数据库(CSCD)来源期刊
《中国学术期刊影响因子年报》统计源期刊
美国化学文摘社(CAS)数据库收录期刊
日本科学技术振兴机构(JST)数据库收录期刊

新发传染病电子杂志 ›› 2026, Vol. 11 ›› Issue (2): 41-44.doi: 10.19871/j.cnki.xfcrbzz.2026.02.008

• 论著 • 上一篇    下一篇

活动性肺结核合并慢性肾脏病患者临床特征和疗效分析

王娟, 高梓铖, 黄苏, 李俊红, 卢庭裕, 俞朝贤   

  1. 呼吸疾病全国重点实验室,广州医科大学结核病防治研究院,广州市胸科医院重症医学科,广东 广州 510095
  • 收稿日期:2025-08-06 出版日期:2026-04-30 发布日期:2026-05-18
  • 通讯作者: 俞朝贤,Email:xyz_1116hhy@163.com
  • 基金资助:
    广东省医学科学技术研究基金项目(2023520174436664)

Clinical characteristics and efficacy analysis of patients with active pulmonary tuberculosis combined with chronic kidney disease

Wang Juan, Gao Zicheng, Huang Su, Li Junhong, Lu Tingyu, Yu Zhaoxian   

  1. Department of Critical Care Medicine, State Key Laboratory of Respiratory Disease, Institute of Tuberculosis, Guangzhou Chest Hospital, Guangdong Guangzhou 510095, China
  • Received:2025-08-06 Online:2026-04-30 Published:2026-05-18

摘要: 目的 探究活动性肺结核合并慢性肾脏病患者临床特征和疗效,为临床诊治提供参考。方法 采用回顾性分析方法,收集2020年1月至2024年12月在广州市胸科医院就诊的活动性肺结核合并慢性肾脏病患者的临床资料,分析其人口学特征、临床表现、实验室检查、影像学表现及治疗效果,并采用χ2检验进行单因素分析,探讨影响疗效的相关因素。结果 纳入患者共74例,男性53例(71.62%),女性21例(28.38%);年龄25~89(中位64)岁。14例(18.92%)合并肺外结核,24例(32.43%)接受肾替代治疗。临床表现主要为咳嗽、咳痰。白细胞升高25例(33.78%),贫血53例(71.62%),尿素氮升高61例(82.43%)。尿蛋白阳性60例(81.08%)。影像学特征主要为两肺斑片状影改变。所有患者均行抗结核治疗,其中44例患者抗结核治疗有效,有效率为59.46%。单因素分析表明,白细胞计数升高(>9.5×109/L)(40.0%比69.39%,χ2=5.931,P=0.015)、尿素氮升高3倍以上(≥21.3mmol/L)(33.30%比67.86%,χ2=6.735,P=0.009)患者疗效较差。结论 活动性肺结核合并慢性肾脏病患者主要为中老年男性,合并肺外结核比例高,总体治疗效果较差;疗效与白细胞水平、尿素氮水平相关。

关键词: 活动性肺结核, 慢性肾脏病, 抗结核治疗, 疗效分析

Abstract: Objective To investigate the clinical characteristics and therapeutic efficacy in patients with active pulmonary tuberculosis combined with chronic kidney disease, and to provide references for the diagnosis and treatment of such patients. Method A retrospective analysis was conducted on the clinical data of patients with pulmonary tuberculosis combined with chronic kidney disease who visited the Guangzhou Chest Hospital from January 2020 to December 2024. Result A total of 74 patients were included, with 53 males (71.62%) and 21 females (28.38%), and their ages ranged from 25 to 89 years (median age,64 years). Among them, 14 patients (18.92%) had extrapulmonary tuberculosis. Twenty-four patients (32.43%) received renal replacement therapy. The main clinical manifestations were cough and sputum production. Elevated white blood cell counts were observed in 25 patients (33.78%), anemia in 53 patients (71.62%), and elevated blood urea nitrogen in 61 patients (82.43%). The urine protein was positive in 60 patients (81.08%). Radiological features were mainly patchy infiltrations. All patients received anti-tuberculosis treatment, among which 44 patients showed improvement, with an effective rate of 59.46%.Univariate analysis indicated that patients with elevated white blood cell counts(>9.5×109/L)(40.0% vs 69.39%, χ2=5.931, P=0.015)and those with blood urea nitrogen levels more than three times the upper limit of normal (≥21.3mmol/L) (33.30% vs 67.86%, χ2=6.735, P=0.009) had poorer therapeutic outcomes. Conclusion Patients with active pulmonary tuberculosis combined with chronic kidney disease are mainly middle-aged and elderly males, with a high proportion of extrapulmonary tuberculosis involvement. The overall therapeutic efficacy is relatively poor, and it is associated with white blood cell and blood urea nitrogen levels.

Key words: Tuberculosis, Chronic Kidney Disease, Anti-tuberculosis treatment, Efficacy analysis

中图分类号: